Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19,395 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mass balance, metabolic disposition, and pharmacokinetics of [14C]ensartinib, a novel potent anaplastic lymphoma kinase (ALK) inhibitor, in healthy subjects following oral administration.
Zhou S, Liu W, Zhou C, Zhang L, Xie L, Xu Z, Wang L, Zhao Y, Guo L, Chen J, Ding L, Mao L, Tao Y, Zhang C, Ding S, Shao F. Zhou S, et al. Among authors: zhou c. Cancer Chemother Pharmacol. 2020 Dec;86(6):719-730. doi: 10.1007/s00280-020-04159-0. Epub 2020 Oct 12. Cancer Chemother Pharmacol. 2020. PMID: 33044566 Clinical Trial.
First-in-Human, Single-Ascending Dose and Food Effect Studies to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cetagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus.
Wang L, Lu J, Zhou S, Zhao Y, Xie L, Zhou C, Chen J, Ding S, Xie D, Ding J, Yu Q, Shen H, Hao G, Shao F. Wang L, et al. Among authors: zhou s, zhou c. Clin Drug Investig. 2021 Nov;41(11):999-1010. doi: 10.1007/s40261-021-01088-5. Epub 2021 Oct 16. Clin Drug Investig. 2021. PMID: 34655432 Clinical Trial.
A double-blind, randomized, placebo and positive-controlled study in healthy volunteers to evaluate pharmacokinetic and pharmacodynamic properties of multiple oral doses of cetagliptin.
Lu J, Wang L, Zhou S, Zhou C, Xie L, Chen J, Tang D, Tian X, Xie D, Ding J, Wang T, Yu Q, Ding J, Shao F. Lu J, et al. Among authors: zhou s, zhou c. Br J Clin Pharmacol. 2022 Jun;88(6):2946-2958. doi: 10.1111/bcp.15209. Epub 2022 Feb 4. Br J Clin Pharmacol. 2022. PMID: 34965609 Free article. Clinical Trial.
Effects of ilaprazole on the steady-state pharmacodynamics of clopidogrel in healthy volunteers: An open-label randomized crossover study.
Ye Z, Chen P, Tan C, Gong X, Li R, Dong Z, Ullah I, Zhou C, Zhou S, Xie L, Hou X, Han Z, Gu Q, Ma J, Teng J, Tang Y, Zhang Z, Hu H, Zhuang Q, Chen J, Zhu B, Shao F, Li C. Ye Z, et al. Among authors: zhou c, zhou s. Front Pharmacol. 2022 Sep 8;13:952804. doi: 10.3389/fphar.2022.952804. eCollection 2022. Front Pharmacol. 2022. PMID: 36160382 Free PMC article.
Pharmacokinetic Interaction of Anaprazole, Amoxicillin and Clarithromycin after Single-Dose Simultaneous Administration and the Effect of Adding Bismuth on Their Pharmacokinetics in Healthy Male Chinese Subjects.
Ding S, Xie L, Wang L, Zhou C, Zhou S, Chen J, Zhu B, Liu Y, Zhu J, Zhang Z, Li T, Wang L, Zhang Z, Shao F. Ding S, et al. Among authors: zhou c, zhou s. Eur J Drug Metab Pharmacokinet. 2023 Mar;48(2):121-132. doi: 10.1007/s13318-022-00810-8. Epub 2022 Dec 15. Eur J Drug Metab Pharmacokinet. 2023. PMID: 36520316 Clinical Trial.
19,395 results
You have reached the last available page of results. Please see the User Guide for more information.